Related Experiment Video
Updated: Apr 18, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Aortic Area as an Indicator of Subclinical Cardiovascular Disease
Allison L Kuipers1, J Jeffrey Carr2, James G Terry2
1Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA.
Insights
Measuring aortic dimensions using computed tomography (CT) can identify early cardiovascular disease (CVD) risk. Larger ascending and descending thoracic aorta areas are linked to subclinical CVD, independent of traditional risk factors.
Area of Science:
- Cardiovascular imaging and disease biomarkers.
- Aortic remodeling and its association with subclinical disease.
Background:
- Outward arterial remodeling is an early sign of cardiovascular disease (CVD).
- Measuring arterial dimensions may serve as an early indicator of subclinical disease.
Purpose of the Study:
- To measure aortic area at the ascending thoracic (ASC), descending thoracic (DSC), and abdominal (ABD) locations.
- To assess the association of these aortic dimensions with traditional CVD risk factors and subclinical CVD.
Main Methods:
- Computed tomography (CT) was used to measure ASC, DSC, and ABD in 408 African ancestry men (aged 50-89).
- Subclinical CVD was assessed via carotid ultrasound, CT for vascular calcification, and pulse-wave velocity (PWV) for arterial stiffness.
- Traditional CVD risk factors were evaluated through interviews and clinical exams.
Main Results:
- All aortic areas were correlated with each other and associated with age, body size, and hypertension.
- After adjusting for traditional risk factors, ASC was linked to carotid atherosclerosis.
- Larger aortic areas at all locations correlated with increased PWV, with the DSC region showing the strongest association.
Conclusions:
- This study is the first to examine multi-site aortic area in relation to subclinical CVD.
- Combined CT assessment of ASC and DSC aortic areas may indicate a high risk of prevalent subclinical CVD.
- These associations were independent of age, body size, and blood pressure.
Aims:
Outward arterial remodeling occurs early in cardiovascular disease (CVD) and, as such, measuring arterial dimension may be an early indicator of subclinical disease. Our objective was to measure area at three aortic locations: the ascending thoracic (ASC), the descending thoracic (DSC), and the abdominal (ABD), and to test for association with traditional CVD risk factors and subclinical CVD throughout the body.
Methods And Results:
We measured ASC, DSC, and ABD using computed tomography (CT) in 408 African ancestry men aged 50-89 years. We assessed prevalent CVD risk factors via participant interview and clinical exam, and subclinical CVD including: carotid atherosclerosis through B-mode carotid ultrasound, vascular calcification via chest and abdominal CT, and arterial stiffness via pulse-wave velocity (PWV). As expected, all aortic areas were correlated with each other (r=0.39-0.63, all p<0.0001) and associated with greater age, greater body size, and hypertension (p≤0.01 for all). After adjustment for traditional CVD risk factors, ASC was positively associated with carotid atherosclerosis (p<0.01). Greater area at each location was associated with greater PWV (p<0.03 for all), with the DSC region showing the most significant association.
Conclusion:
This is the first study to test the association of aortic area measured at multiple points with subclinical CVD. We found that combined CT assessment of ascending and descending aortic area may indicate high risk of prevalent subclinical CVD elsewhere in the body independent of age, body size, and blood pressure.
More Related Videos
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Aortic Regurgitation I: Introduction
Aortic Regurgitation III: Medical Management

